Jean-Luc Harousseau
Centre Hospitalier Universitaire Hôtel-Dieu
Nantes
France
Name/email consistency: high
- Induction therapy in multiple myeloma. Harousseau, J.L. Hematology. Am. Soc. Hematol. Educ. Program (2008)
- Role of stem cell transplantation. Harousseau, J.L. Hematol. Oncol. Clin. North Am. (2007)
- A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. Harousseau, J.L., Lancet, J.E., Reiffers, J., Lowenberg, B., Thomas, X., Huguet, F., Fenaux, P., Zhang, S., Rackoff, W., De Porre, P., Stone, R. Blood (2007)
- The allogeneic dilemma. Harousseau, J.L. Bone Marrow Transplant. (2007)
- Role of bone marrow transplantation in the disease pathway of myeloma. Harousseau, J.L., Moreau, P. J. Natl. Compr. Canc. Netw (2007)
- Farnesyltransferase inihibitors in hematologic malignancies. Harousseau, J.L. Blood Rev. (2007)
- Thalidomide in multiple myeloma: past, present and future. Harousseau, J.L. Future. Oncology. (london,. England) (2006)